Possible case of potentiation of the antiplatelet effect of cilostazol by grapefruit juice.
We present a case of purpura associated with concomitant ingestion of cilostazol, aspirin and grapefruit juice. A 79-year-old man with atherosclerosis obliterans, taking cilostazol and aspirin, complained of purpura. Interview by a pharmacist revealed that he had been taking grapefruit juice for a month. His purpura disappeared upon cessation of grapefruit juice, although his medication was not altered. The most probable cause of his purpura is an increase in the blood level of cilostazol because of the inhibition of cilostazol metabolism by components of grapefruit juice. Aspirin may possibly have potentiated the risk of purpura. Grapefruit juice should be avoided in patients taking cilostazol, especially in patients being concomitantly treated with other anticoagulants.
Taniguchi
K
K
Nara Kouseikai Hospital, Nara, Japan.
Ohtani
H
H
Ikemoto
T
T
Miki
A
A
Hori
S
S
Sawada
Y
Y
D000368:Aged; D001241:Aspirin / Q000009:adverse effects* / Q000493:pharmacokinetics; D001628:Beverages; D000077407:Cilostazol; D002957:Citrus; D018565:Food-Drug Interactions; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics; D011693:Purpura / Q000139:chemically induced; D013777:Tetrazoles / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics
D010975:Platelet Aggregation Inhibitors; D013777:Tetrazoles; D000077407:Cilostazol; D001241:Aspirin